Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Novo Holdings A/S
Form 13F · Q2 2026

Novo Holdings A/S

CIK 1388325申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$17.2亿
申报组合市值
25
持仓数量
12
Quarters on record
Top 50
持仓数量

Novo Holdings A/S——持仓

共 25 个持仓中的前 25 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1EWTX Edgewise Therapeutics Inc5.3M+0.0%$2.2亿12.6%
2ASML Asml Hldg Nv94,946+0.0%$1.9亿11.0%
3COAG Hemab Therapeutics Hldgs Inc4.2M—$1.5亿8.9%
4BN Brookfield Corp3.5M+0.0%$1.5亿8.7%
5MPLT Maplight Therapeutics Inc3.7M+0.0%$1.3亿7.7%
6MIRM Mirum Pharmaceuticals Inc1.1M−15.1%$1.3亿7.6%
7AVLN Avalyn Pharmaceuticals Inc3.9M—$1.3亿7.4%
8CRM Salesforce Inc393,187+0.0%$6160万3.6%
9AVBP Arrivent Biopharma Inc1.5M−22.8%$5211万3.0%
10ELVN Enliven Therapeutics Inc1.0M−21.9%$5075万2.9%
11CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In1.3M−14.8%$4939万2.9%
12PHVS Pharvaris N V1.4M−20.0%$4841万2.8%
13FND Floor & Decor Hldgs Inc797,000—$4731万2.7%
14PCVX Vaxcyte Inc800,000−7.0%$4650万2.7%
15FDMT 4D Molecular Therapeutics In3.2M−11.0%$4321万2.5%
16VRDN Viridian Therapeutics Inc2.1M+6.8%$3922万2.3%
17CLDX Celldex Therapeutics Inc New1.0M−14.6%$3814万2.2%
18ALMS Alumis Inc1.1M—$3095万1.8%
19XENE Xenon Pharmaceuticals Inc485,438+0.0%$2930万1.7%
20BABA Alibaba Group Hldg Ltd257,327+0.0%$2470万1.4%
21DYN Dyne Therapeutics Inc960,394—$2133万1.2%
22BBOT Bridgebio Oncology Therapeut2.2M+2.9%$1714万1.0%
23INSM Insmed Inc120,723—$1287万0.7%
24MQ Marqeta Inc441,558+0.0%$717万0.4%
25LNZA Lanzatech Global Inc158,148+0.0%$108万0.1%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。